GT200000190A - Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas. - Google Patents

Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.

Info

Publication number
GT200000190A
GT200000190A GT200000190A GT200000190A GT200000190A GT 200000190 A GT200000190 A GT 200000190A GT 200000190 A GT200000190 A GT 200000190A GT 200000190 A GT200000190 A GT 200000190A GT 200000190 A GT200000190 A GT 200000190A
Authority
GT
Guatemala
Prior art keywords
tetrahydrochinolines
carboxyamin
substituted
procedure
obtaining
Prior art date
Application number
GT200000190A
Other languages
English (en)
Spanish (es)
Inventor
David Burns Damon
Robert Wayne Dugger
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of GT200000190A publication Critical patent/GT200000190A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GT200000190A 1999-11-30 2000-11-03 Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas. GT200000190A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16796799P 1999-11-30 1999-11-30

Publications (1)

Publication Number Publication Date
GT200000190A true GT200000190A (es) 2002-04-27

Family

ID=22609556

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200000190A GT200000190A (es) 1999-11-30 2000-11-03 Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.

Country Status (44)

Country Link
US (1) US6313142B1 (forum.php)
EP (1) EP1125929B1 (forum.php)
JP (1) JP3579345B2 (forum.php)
KR (1) KR100408177B1 (forum.php)
CN (1) CN1173953C (forum.php)
AP (1) AP2000002011A0 (forum.php)
AR (1) AR029775A1 (forum.php)
AT (1) ATE315028T1 (forum.php)
AU (1) AU784694B2 (forum.php)
BG (1) BG105009A (forum.php)
BR (1) BR0005636A (forum.php)
CA (1) CA2327029C (forum.php)
CO (1) CO5261552A1 (forum.php)
CY (1) CY1104989T1 (forum.php)
CZ (1) CZ20004407A3 (forum.php)
DE (1) DE60025317T2 (forum.php)
DK (1) DK1125929T3 (forum.php)
DZ (1) DZ3079A1 (forum.php)
EA (1) EA003668B1 (forum.php)
EE (1) EE200000659A (forum.php)
ES (1) ES2254109T3 (forum.php)
GE (1) GEP20022798B (forum.php)
GT (1) GT200000190A (forum.php)
HN (1) HN2000000203A (forum.php)
HR (1) HRP20000804A2 (forum.php)
HU (1) HUP0004747A3 (forum.php)
ID (1) ID28489A (forum.php)
IL (1) IL139849A (forum.php)
IS (1) IS5715A (forum.php)
MA (1) MA25223A1 (forum.php)
NO (1) NO20006039L (forum.php)
NZ (1) NZ508509A (forum.php)
OA (1) OA11494A (forum.php)
PA (1) PA8503801A1 (forum.php)
PE (1) PE20010913A1 (forum.php)
PL (1) PL344208A1 (forum.php)
SG (1) SG102603A1 (forum.php)
SK (1) SK17792000A3 (forum.php)
TN (1) TNSN00230A1 (forum.php)
TW (1) TW591016B (forum.php)
UA (1) UA65615C2 (forum.php)
UY (1) UY26451A1 (forum.php)
YU (1) YU71500A (forum.php)
ZA (1) ZA200006947B (forum.php)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
WO2003053359A2 (en) 2001-12-19 2003-07-03 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
HUP0500165A2 (en) * 2001-12-19 2006-09-28 Atherogenics Inc Chalcone derivatives and their use to treat diseases
AU2003230916A1 (en) * 2002-04-11 2003-10-27 Roar Holding Llc Ex vivo method for determination of cetp activity and efficacy of heart disease treatment
US20090181966A1 (en) * 2002-10-04 2009-07-16 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7504508B2 (en) * 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
CN100363348C (zh) * 2002-10-04 2008-01-23 千禧药品公司 治疗炎性疾病的前列腺素d2受体拮抗剂
US7223870B2 (en) * 2002-11-01 2007-05-29 Pfizer Inc. Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
WO2004056727A2 (en) * 2002-12-19 2004-07-08 Atherogenics, Inc. Process of making chalcone derivatives
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
EP1961419B1 (en) 2002-12-20 2010-03-24 Pfizer Products Inc. Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor
US20060100239A1 (en) * 2003-03-04 2006-05-11 Izuru Nagasaki Method for producing optically active amines
KR20080008440A (ko) * 2003-03-17 2008-01-23 니뽄 다바코 산교 가부시키가이샤 Ｃｅｔｐ 억제제의 약제학적 조성물
KR20050110017A (ko) * 2003-03-17 2005-11-22 니뽄 다바코 산교 가부시키가이샤 Ｓ-'２-(''１-(２-에틸부틸)시클로헥실!카르보닐!아미노)페닐!-２-메틸프로판티오에이트의 경구 생체이용율을증가시키는 방법
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
PT1670768E (pt) * 2003-10-08 2009-11-20 Lilly Co Eli Compostos e métodos para tratamento de dislipidemia
UA90269C2 (ru) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагидрохинолиновые производные и способ их получения
EP1761521A1 (en) * 2004-06-24 2007-03-14 Eli Lilly And Company Compounds and methods for treating dyslipidemia
DOP2005000123A (es) 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006033001A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Quinoline compounds
WO2006069162A1 (en) * 2004-12-20 2006-06-29 Reddy Us Therapeutics, Inc. Novel heterocyclic compounds and their pharmaceutical compositions
GT200600093A (es) * 2005-02-24 2006-10-19 Antagonistas del receptor de pgd2 para el tratamiento de enfermedades inflamatorias
UY30244A1 (es) 2006-03-30 2007-11-30 Tanabe Seiyaku Co Un proceso para preparar derivados de tetrahidroquinolina
WO2008112166A2 (en) 2007-03-09 2008-09-18 Indigene Pharmaceuticals Inc. Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
CN101429160B (zh) * 2007-11-06 2011-10-19 上海药明康德新药开发有限公司 一种1-r-4-氨基-1,2,3,4-四氢喹啉的合成方法
TWI450896B (zh) 2009-06-30 2014-09-01 Lilly Co Eli 反式－４－〔〔（５ｓ）－５－〔〔〔３，５－雙（三氟甲基）苯基〕甲基〕（２－甲基－２ｈ－四唑－５－基）胺基〕－２，３，４，５－四氫－７，９－二甲基－１ｈ－１－苯并氮呯－１－基〕甲基〕－環己基羧酸
IL317973A (en) 2022-07-05 2025-02-01 Newamsterdam Pharma B V Salts of ovicetrapib and processes for their production and intermediates

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7870M (forum.php) * 1968-11-08 1970-04-27
US3971789A (en) 1972-10-21 1976-07-27 John Wyeth & Brother Limited O-(4-Quinolylamino)benzamides
GB8432091D0 (en) 1984-12-19 1985-01-30 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US4839368A (en) 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
GB8804444D0 (en) 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5231102A (en) 1989-03-08 1993-07-27 Merck Sharp & Dohme, Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6197786B1 (en) 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6140342A (en) 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6147089A (en) 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.

Also Published As

Publication number Publication date
JP3579345B2 (ja) 2004-10-20
PL344208A1 (en) 2001-06-04
MA25223A1 (fr) 2001-07-02
ES2254109T3 (es) 2006-06-16
NO20006039D0 (no) 2000-11-29
OA11494A (en) 2004-05-07
PA8503801A1 (es) 2002-07-30
HUP0004747A3 (en) 2002-12-28
JP2001163859A (ja) 2001-06-19
AP2000002011A0 (en) 2000-12-31
DE60025317D1 (de) 2006-03-30
HU0004747D0 (forum.php) 2001-02-28
AU784694B2 (en) 2006-06-01
HK1038007A1 (en) 2002-03-01
IL139849A0 (en) 2002-02-10
DK1125929T3 (da) 2006-04-03
ID28489A (id) 2001-05-31
EE200000659A (et) 2001-08-15
TNSN00230A1 (fr) 2005-11-10
TW591016B (en) 2004-06-11
BG105009A (en) 2001-11-30
CY1104989T1 (el) 2010-03-03
UA65615C2 (uk) 2004-04-15
DE60025317T2 (de) 2006-08-03
NZ508509A (en) 2001-06-29
ATE315028T1 (de) 2006-02-15
EP1125929B1 (en) 2006-01-04
AR029775A1 (es) 2003-07-16
IL139849A (en) 2006-10-31
DZ3079A1 (fr) 2004-10-24
UY26451A1 (es) 2001-06-29
KR100408177B1 (ko) 2003-12-01
CN1302800A (zh) 2001-07-11
BR0005636A (pt) 2001-07-17
HN2000000203A (es) 2001-06-13
EA200001129A2 (ru) 2001-06-25
IS5715A (is) 2001-05-31
ZA200006947B (en) 2002-05-27
PE20010913A1 (es) 2001-09-10
US6313142B1 (en) 2001-11-06
CO5261552A1 (es) 2003-03-31
SK17792000A3 (sk) 2002-10-08
AU7178900A (en) 2001-05-31
GEP20022798B (en) 2002-09-25
CA2327029A1 (en) 2001-05-30
EA200001129A3 (ru) 2001-10-22
CN1173953C (zh) 2004-11-03
KR20010052012A (ko) 2001-06-25
HUP0004747A2 (hu) 2001-10-28
EP1125929A1 (en) 2001-08-22
YU71500A (sh) 2003-02-28
NO20006039L (no) 2001-05-31
HRP20000804A2 (en) 2001-06-30
SG102603A1 (en) 2004-03-26
EA003668B1 (ru) 2003-08-28
CA2327029C (en) 2005-08-09
CZ20004407A3 (cs) 2002-06-12

Similar Documents

Publication Publication Date Title
GT200000190A (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
CR6895A (es) Nuevos compuestos heterociclicos su preparacion y su utilizacion como medicamentos en especial como antibacterianos
ES2183943T3 (es) Productos intermedios y procedimiento para la fabricacion de derivados de camptotecina (cpt-11) y compuestos relacionados.
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
ECSP034437A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos
HN1998000020A (es) Derivados de acido arilsulfonilhidroxamico.
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
PA8559401A1 (es) Sales de acido succinico de 5,7,14-triazatetraciclo (10.3.1.0 2,11.0 4, 9)-hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
ES2150808T3 (es) Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
BR0112245B1 (pt) Éster de ácido 4-alcóxi-ciclohexano-1-amino-carboxílico
HN2001000278A (es) Procedimiento para la preparacion de imidazotriazininas substituidas con sulfonamida.
CY1107635T1 (el) Μεθοδος για την παρασκευη σιταλοπραμης
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
DE60015508D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
EA200100129A1 (ru) Способ получения гидроксиметилтиобутановой кислоты
ES2160978T3 (es) Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion.
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
FR2796641B1 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
ES2177877T3 (es) Procedimiento para la fabricacion de 1,4-bis(aminometil)ciclohexano.
AR005878A1 (es) Procedimiento para la elaboracion del ester metilico del acido 2-(2- metilfenil)-3-metoxiacrilico
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
AR025028A1 (es) Procedimiento para preparar acidos a traves de alfa-cloroepoxi-esteres
AR037493A1 (es) Proceso para la preparacion de hidrobromuro de citalopram